ORGS
- Orgenesis Inc.
()
Overview
Company Summary
Orgenesis Inc. (ORGS) is a biotechnology company that focuses on developing advanced cell therapies to cure serious diseases. The company is dedicated to revolutionizing the way we treat various medical conditions, using their innovative platform called Autologous Cell Therapy (ACT), which involves harnessing patients' own cells to create personalized therapies.
Orgenesis operates through two primary subsidiaries: MaSTherCell Global and Orgenesis Maryland. MaSTherCell Global is a Contract Development and Manufacturing Organization (CDMO) specializing in cell therapy production. They provide a full range of services to support the development and production of cell-based therapeutics for other organizations within the healthcare industry.
Orgenesis Maryland, on the other hand, focuses on developing its proprietary cell therapy technologies and therapeutic pipeline. They are engaged in research and development activities to expand the potential application of ACT platform across multiple diseases and conditions. This includes exploring treatments for diabetes, liver disease, and other disorders that can be addressed through cell-based therapies.
In summary, Orgenesis Inc. is using its expertise in cell therapy and personalized medicine to develop innovative treatments for serious diseases. They provide services to other organizations seeking to develop their own cell-based therapeutics, as well as driving their own research and development initiatives to advance their proprietary ACT platform.